SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-20-036934
Filing Date
2020-11-13
Accepted
2020-11-13 16:20:12
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea129831-f3_alteritytherap.htm F-3 252377
2 REGISTRATION RIGHTS AGREEMENT ea129831ex4-4_alterity.htm EX-4.4 106270
3 OPINION OF QUINERT RODDA & ASSOCIATES PTY LTD. REGARDING LEGALITY OF THE SECURIT ea129831ex5-1_alterity.htm EX-5.1 13453
4 CONSENT OF PRICEWATERHOUSECOOPERS, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea129831ex23-1_alterity.htm EX-23.1 2179
5 GRAPHIC image_001.jpg GRAPHIC 8571
6 GRAPHIC ex5-1_001.jpg GRAPHIC 65397
7 GRAPHIC ex5-1_002.jpg GRAPHIC 26722
  Complete submission text file 0001213900-20-036934.txt   514436
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-3 | Act: 33 | File No.: 333-250076 | Film No.: 201311745
SIC: 2834 Pharmaceutical Preparations